TherapeuticsMD Inc (TXMD)

TherapeuticsMD Inc (TXMD) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $23.8M; returns 1 day -2.7%, 1 week -5.3%, 1 year +37.4%.

TherapeuticsMD, Inc. operates as a pharmaceutical company focused on women's healthcare. It transitioned to a pharmaceutical royalty company in December 2022 and no longer engages in R&D or commercial operations. The company generates revenue through royalties from licensing agreements, primarily the Mayne License Agreement, for products addressing hormone therapy and contraception.

Groups TXMD belongs to

TXMD financial model: income statement, cash flow and balance sheet